Evaluation of the effects of medium-term (57-day) omeprazole administration and of omeprazole discontinuation on serum gastrin and serum chromogranin A concentrations in the horse.

dc.citation.issue4
dc.citation.volume37
dc.contributor.authorClark B
dc.contributor.authorSteel C
dc.contributor.authorVokes J
dc.contributor.authorShan JR
dc.contributor.authorGedye K
dc.contributor.authorLovett A
dc.contributor.authorSykes BW
dc.coverage.spatialUnited States
dc.date.accessioned2024-08-26T02:58:12Z
dc.date.available2024-08-26T02:58:12Z
dc.date.issued2023-07-01
dc.description.abstractBACKGROUND: Rebound gastric hyperacidity (RGH) secondary to hypergastrinemia has been suggested to contribute to the rapid recurrence of equine squamous gastric disease (ESGD) in horses after discontinuation of omeprazole. HYPOTHESIS/OBJECTIVES: To evaluate changes in serum gastrin and chromogranin A (CgA) concentrations in response to medium-term (57-day) omeprazole treatment and after omeprazole discontinuation. ANIMALS: Fourteen mature Thoroughbred racehorses in simulated race training. METHODS: Horses received 2.28 g of oral omeprazole PO q24h for 57 days within a 61-day period, excluding a withholding period applied mid-protocol during which treatment was stopped as part of a concurrent study. Serum samples were collected on day 0 before omeprazole treatment, on day 1 of each week of the treatment period, and for an additional 5 weeks after discontinuation of treatment. Serum gastrin and CgA concentrations were analyzed using radioimmunoassay (RIA) and ELISA, respectively. RESULTS: Median serum gastrin concentrations increased 2.5-fold from baseline to day 7 (P < .001) but did not increase further during the omeprazole treatment period. Median serum gastrin concentrations returned to baseline within 2 to 4 days after administration of the last dose of omeprazole. No effect of treatment or discontinuation was seen in serum CgA concentrations. CONCLUSIONS AND CLINICAL IMPORTANCE: Serum gastrin concentrations increased in response to omeprazole treatment but returned to baseline within 2 to 4 days after the last dose of omeprazole. No effect of treatment or discontinuation was seen in serum CgA concentrations. Our results do not support the use of tapering protocols in horses.
dc.description.confidentialfalse
dc.edition.editionJuly 2023
dc.format.pagination1537-1543
dc.identifier.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/37390114
dc.identifier.citationClark B, Steel C, Vokes J, Shan JR, Gedye K, Lovett A, Sykes BW. (2023). Evaluation of the effects of medium-term (57-day) omeprazole administration and of omeprazole discontinuation on serum gastrin and serum chromogranin A concentrations in the horse.. J Vet Intern Med. 37. 4. (pp. 1537-1543).
dc.identifier.doi10.1111/jvim.16795
dc.identifier.eissn1939-1676
dc.identifier.elements-typejournal-article
dc.identifier.issn0891-6640
dc.identifier.urihttps://mro.massey.ac.nz/handle/10179/71382
dc.languageeng
dc.publisherJohn Wiley and Sons, Inc.
dc.publisher.urihttps://onlinelibrary.wiley.com/doi/10.1111/jvim.16795
dc.relation.isPartOfJ Vet Intern Med
dc.rights(c) 2023 The Author/s
dc.rightsCC BY 4.0
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectESGD
dc.subjectequine
dc.subjecthypergastrinemia
dc.subjectrebound gastric hyperacidity
dc.subjectstomach
dc.subjectHorses
dc.subjectAnimals
dc.subjectOmeprazole
dc.subjectChromogranin A
dc.subjectAnti-Ulcer Agents
dc.subjectGastrins
dc.subjectStomach
dc.titleEvaluation of the effects of medium-term (57-day) omeprazole administration and of omeprazole discontinuation on serum gastrin and serum chromogranin A concentrations in the horse.
dc.typeJournal article
pubs.elements-id477833
pubs.organisational-groupOther
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Published version.pdf
Size:
790.69 KB
Format:
Adobe Portable Document Format
Description:
477833 PDF.pdf
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
9.22 KB
Format:
Plain Text
Description:
Collections